Bausch Advances Novel Dry Eye Therapeutic to Phase 3

Quebec based B+L has announced the second of two Phase 3 studies studies evaluating the investigational treatment NOV03 (perfluorohexyloctane) as a first-in- class investigational drug to treat the signs and symptoms of Dry Eye Disease (DED) associated with Meibomian gland dysfunction (MGD).

According to the company, the new proprietary compound NOV03 is a proprietary, water-free and preservative-free solution, based on patented EyeSol® technology from German company, Novaliq GmbH. The drug has a novel mechanism of action to treat Dry Eye Disease associated with MGD.

NOV03 showed statistically significant improvement of certain symptoms, such as severity and frequency of dryness and burning/stinging of the eyes, over the entire duration of the Phase 2 study (336 patients) with no notable safety events.

View the full Press Release from B+L

Featured Posts

Bausch + Lomb Launches Biotrue® Advanced Multi-Purpose Solution in Canada

New Formula Provides More Moisture on Contact Lenses

Learn More

SILMO Istanbul 2022: A Record Attendance

SILMO ISTANBUL welcomed both local manufacturers and a number of international companies of the optical and eyewear industry.

Read more

Silhouette’s Visionary Rimless Momentum Aurum Sets a New Trend in the Luxury Market

Inspired by fine watches and jewelry, Silhouette has designed a very special pair of premium eyewear.

Read more

UdeM School of Optometry Shares Study Findings on Accuracy of Purchasing Prescription Glasses Online

Findings from a recently completed empirical study conducted by the Université de Montréal (UdeM) unveils that New Look’s Topology delivers better quality eyewear than the technologies of two major online eyewear retailers, and, when they received the new glasses, the participants judged them to be comparable to what is found in store.

Read more

Understanding the Impact of an Inherited Retinal Disease for Canadians

FBC published a study in the Canadian Journal of Ophthalmology about the physical, emotional and practical challenges that individuals with an inherited retinal disease (IRD) face in Canada.

Read more

Bausch + Lomb Launches Biotrue® Advanced Multi-Purpose Solution in Canada

New Formula Provides More Moisture on Contact Lenses

Learn More

SILMO Istanbul 2022: A Record Attendance

SILMO ISTANBUL welcomed both local manufacturers and a number of international companies of the optical and eyewear industry.

Read More

Silhouette’s Visionary Rimless Momentum Aurum Sets a New Trend in the Luxury Market

Inspired by fine watches and jewelry, Silhouette has designed a very special pair of premium eyewear.

Read More

UdeM School of Optometry Shares Study Findings on Accuracy of Purchasing Prescription Glasses Online

Findings from a recently completed empirical study conducted by the Université de Montréal (UdeM) unveils that New Look’s Topology delivers better quality eyewear than the technologies of two major online eyewear retailers, and, when they received the new glasses, the participants judged them to be comparable to what is found in store.

Read More

Understanding the Impact of an Inherited Retinal Disease for Canadians

FBC published a study in the Canadian Journal of Ophthalmology about the physical, emotional and practical challenges that individuals with an inherited retinal disease (IRD) face in Canada.

Read More

Bausch + Lomb Launches Biotrue® Advanced Multi-Purpose Solution in Canada

New Formula Provides More Moisture on Contact Lenses

Learn More

SILMO Istanbul 2022: A Record Attendance

SILMO ISTANBUL welcomed both local manufacturers and a number of international companies of the optical and eyewear industry.

Read more

Silhouette’s Visionary Rimless Momentum Aurum Sets a New Trend in the Luxury Market

Inspired by fine watches and jewelry, Silhouette has designed a very special pair of premium eyewear.

Read more

UdeM School of Optometry Shares Study Findings on Accuracy of Purchasing Prescription Glasses Online

Findings from a recently completed empirical study conducted by the Université de Montréal (UdeM) unveils that New Look’s Topology delivers better quality eyewear than the technologies of two major online eyewear retailers, and, when they received the new glasses, the participants judged them to be comparable to what is found in store.

Read more

Understanding the Impact of an Inherited Retinal Disease for Canadians

FBC published a study in the Canadian Journal of Ophthalmology about the physical, emotional and practical challenges that individuals with an inherited retinal disease (IRD) face in Canada.

Read more

Bausch + Lomb Launches Biotrue® Advanced Multi-Purpose Solution in Canada

New Formula Provides More Moisture on Contact Lenses

Learn More

SILMO Istanbul 2022: A Record Attendance

SILMO ISTANBUL welcomed both local manufacturers and a number of international companies of the optical and eyewear industry.

Read more

Silhouette’s Visionary Rimless Momentum Aurum Sets a New Trend in the Luxury Market

Inspired by fine watches and jewelry, Silhouette has designed a very special pair of premium eyewear.

Read more

UdeM School of Optometry Shares Study Findings on Accuracy of Purchasing Prescription Glasses Online

Findings from a recently completed empirical study conducted by the Université de Montréal (UdeM) unveils that New Look’s Topology delivers better quality eyewear than the technologies of two major online eyewear retailers, and, when they received the new glasses, the participants judged them to be comparable to what is found in store.

Read more

Understanding the Impact of an Inherited Retinal Disease for Canadians

FBC published a study in the Canadian Journal of Ophthalmology about the physical, emotional and practical challenges that individuals with an inherited retinal disease (IRD) face in Canada.

Read more